Nicky Agahari
CEO and co-founder
Australis Scientific
Australis Scientific develops novel, minimally invasive neuromodulation devices to transform patient treatment approaches. The company focuses on creating convenient medical device solutions, such as the Confidanz® Smart Patch for overactive bladder management. These technologies aim to enhance the quality of life for patients globally through advanced medical innovation.
- Digital Health
- Hardware
- Healthcare Technology
- Medical Devices
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Lower Urinary Tract Symptoms (LUTS), such as urinary frequency and urgency, significantly impact patient quality of life. Traditional treatments for urinary incontinence can be invasive and may not be suitable for all patients. There is a need for effective, non-invasive alternatives to manage LUTS.
Solution
Australis Scientific's InConfidence SmartPatch is a non-invasive medical device utilizing percutaneous posterior tibial nerve stimulation (PTNS) technology to treat LUTS. The SmartPatch offers a patient-friendly alternative to invasive procedures, providing measurable improvements in urinary frequency and urgency. By employing neural modulation, the device aims to restore bladder control and reduce the burden of LUTS on daily life. The technology provides a discreet and convenient method for managing urinary symptoms.
Target Audience
The primary target audience includes individuals experiencing Lower Urinary Tract Symptoms (LUTS) such as urinary frequency and urgency, and healthcare professionals seeking non-invasive treatment options for their patients.
Features
- Percutaneous posterior tibial nerve stimulation (PTNS) technology
- Non-invasive application via SmartPatch
- Designed for the treatment of Lower Urinary Tract Symptoms (LUTS)
- Aims to improve urinary frequency and urgency
- Provides an alternative to traditional invasive treatments